Santhera Pharmaceuticals Holding AG

<!-- Name:DistributionId Value:1000781331 --> <!-- Name:NewsArchiveTags Value:2428,2664,2701 --> <!-- Name:NewsArchiveOrgTags…

Ad hoc announcement pursuant to Art. 53 LR Pratteln, Switzerland, January 10, 2023 – Santhera Pharmaceuticals (SIX: SANN) announces that through a share exchange it will receive the equivalent of CHF 5 million Idorsia shares which…

Pratteln, Switzerland, November 29, 2022 – Santhera Pharmaceuticals (SIX: SANN) announces that its shareholders have approved all proposals by the Board of Directors at the Extraordinary General Meeting (EGM) held today at the Company’s…